Back

Which patients will benefit most from FXI inhibition?

29 August 2022 (15:50 - 16:05)
Organised by:
Congress Presentation Part of: How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention Atrial Fibrillation (AF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor M. Patel (Durham, US)
Presentation thumbnail
What makes FXI inhibition different from current approaches to thrombosis prevention?
Professor V. Caso (Perugia, IT)
Presentation thumbnail
Live Q&A.

Access the full session

Session thumbnail
How could factor eleven (FXI) inhibitors help your patients? New frontiers in thrombosis prevention

The Event

Event poster

ESC Congress 2022

29 August 2022 15:50 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources